Q32 Bio (QTTB) Times Interest Earned (2017 - 2026)

Q32 Bio (QTTB) posted quarterly Times Interest Earned of -$0.92 for Q1 2026, up 91.51% year-over-year from -$0.48 in Q1 2025, and down 100.4% quarter-over-quarter from $229.4 in Q4 2025.

Q32 Bio (QTTB) Times Interest Earned (2017 - 2026) Analysis & Trends

Q32 Bio's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$0.92 for Q1 2026.

  • In Q1 2026, Times Interest Earned rose 91.51% year-over-year to -$0.92; the TTM figure through Mar 2026 stood at $2.56 (up 104.53% YoY), while the FY2025 annual figure was $2.39, up 487.02% from the prior year.
  • Times Interest Earned for Q1 2026 stood at -$0.92, down from $229.4 in the prior quarter.
  • The five-year high for Times Interest Earned was $229.4 in Q4 2025, with the low at -$36.32 in Q4 2024.
  • The 5-year median for Times Interest Earned is -$1.4 (2024), against an average of $5.77.
  • The sharpest annual moves came in 2023 and 2025: Times Interest Earned plunged 4663.54% in 2023, then jumped 731.68% in 2025.
  • Q32 Bio's Times Interest Earned stood at -$0.19 in 2022, then sank by 3260.47% to -$6.45 in 2023, then slumped by 462.83% to -$36.32 in 2024, then surged by 731.68% to $229.4 in 2025, then plunged by 100.4% to -$0.92 in 2026.
  • Business Quant data shows QTTB's Times Interest Earned at -$0.92 in Q1 2026, $229.4 in Q4 2025, and -$6.74 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.84
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 24.64
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -0.19
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8.18
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -0.01
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.61
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.82
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.08
10 Q32 Bio 359.61 Mn 253.31 Mn - -0.42

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.42
Mar 31, 2026 -0.92
Dec 31, 2025 229.40
Sep 30, 2025 -6.74
Jun 30, 2025 -1.21
Mar 31, 2025 -10.88
Dec 31, 2024 -36.32
Sep 30, 2024 -0.30
Jun 30, 2024 -1.49
Mar 31, 2024 -1.40
Dec 31, 2023 -6.45
Sep 30, 2023 -15.98
Jun 30, 2023 -28.87
Mar 31, 2023 -18.43
Dec 31, 2022 -0.19
Sep 30, 2022 -0.71
Jun 30, 2022 -0.61
Mar 31, 2022 -0.79
Dec 31, 2021 -0.21
Sep 30, 2021 -1.77